LYB Stock Analysis — LyondellBasell Industries
Sector: Chemicals
AI Verdict
LYB is cheap for a reason at 6.7x forward earnings, but unless the scale moat can offset the -22.0% revenue slide, the low valuation alone isn’t a buy signal.
Competitive Moat
LyondellBasell operates some of the world’s largest integrated petrochemical complexes, giving it scale and cost advantages in commodity plastics and chemicals. Its moat is primarily from high barriers to entry due to capital intensity and technical expertise, rather than product differentiation.
Summary
RSI of 17.8 puts LYB in deeply oversold territory after a -14.29% one-year return.
Where It Stands
LYB trades at just 6.7x forward earnings, far below the chemicals sector’s typical 15–20x, with an RSI of 17.8 signaling extreme oversold conditions and a -22.0% revenue decline in the last year.
Key Metrics
- RSI: 17.8 — Oversold
- Forward P/E: 6.7x
- Revenue Growth: -0.2%
- Market Cap: $17.6B
- Dividend Yield: 0.05%
- 1-Year Return: -14.29%
- 52-Week High: $83.94
- 52-Week Low: $41.58
Analyst Consensus
11 Buy · 10 Hold · 4 Sell (25 analysts)
Bull Case
At 6.7x forward P/E, the stock is priced for minimal growth, so any stabilization or rebound could spark a sharp re-rating from these levels.
Bear Case
If the forward P/E were to even partially re-rate to 10x on further earnings declines, investors could still face double-digit downside from here, especially with -22.0% revenue growth showing no turnaround yet.
Catalyst to Watch
Watch for quarterly earnings or guidance updates—any sign of revenue stabilization or cost discipline could trigger a relief rally from the current RSI extreme.